Results 141 to 150 of about 132,650 (237)

Effect of Butyrate-Producing Enterobacteria and Proton Pump Inhibitors on Advanced Hepatocellular Carcinoma Treatment With Durvalumab and Tremelimumab. [PDF]

JGH Open
Nouso K, Wakuta A, Shiota S, Fujita R, Kariyama K, Hiraoka A, Atsukawa M, Tani J, Tada T, Nakamura S, Tajiri K, Kaibori M, Hirooka M, Itobayashi E, Kakizaki S, Naganuma A, Ishikawa T, Imai M, Aoki T, Tanaka H, Hatanaka T, Tsuji K, Kawata K, Takaguchi K, Tsutsui A, Ogawa C, Ochi H, Yata Y, Kuroda H, Matono T, Yasuda S, Toyoda H, Iijima H, Kudo M, Kumada T.   +34 more
europepmc   +1 more source

Deleterious effect of proton pump inhibitors on the disease course of cirrhosis [PDF]

, 2018
Zsuzsanna Vitális, Tamás Janka, Tamás Tornai, István Tornai, Dávid Tornai, Mária Papp   +5 more
openalex   +1 more source

Proton Pump Inhibitors and Risk of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Almabruk BA, Alsulami GA, Alzahrani A, Alsulami EA, Badawood AA, Alghanim AS, Alresheedi FF, Alharbi RS, Alghamdi HA.   +8 more
europepmc   +1 more source

Self-medication with proton pump inhibitors among physicians in Bosnia and Herzegovina: a cross-sectional study. [PDF]

Front Med (Lausanne)
Jovanovic P, Bokan G, Basic Denjagic M, Salkic N, Kurtcehajic A, Gavric A, Ljuca K, Tadic M, Mesihovic R, Hauser G, Zerem D.   +10 more
europepmc   +1 more source

Risk of Depression Related to Use of Proton Pump Inhibitors and Tegoprazan: A Nationwide Cohort Study. [PDF]

J Korean Med Sci
Kim S, Kim JS.
europepmc   +1 more source

Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis [PDF]

, 2015
Javier Molina‐Infante, Albert J. Bredenoord, Edaire Cheng, Evan S. Dellon, Glenn T. Furuta, Sandeep K. Gupta, Ikuo Hirano, David A. Katzka, Fouad J. Moawad, Marc E. Rothenberg, Alain Schoepfer, Stuart J. Spechler, Ting Wen, Alex Straumann, Alfredo J. Lucendo   +14 more
openalex   +1 more source

Balancing therapeutic benefits and hidden risks of proton pump inhibitors in pediatric practice: a narrative review and update. [PDF]

Clin Exp Pediatr
Rogalidou M, Papadopoulou A.
europepmc   +1 more source

Comparison of the Safety of Proton Pump Inhibitors and Histamine Type 2-Receptor Antagonists in the Prevention of Gastrointestinal Complications. [PDF]

Cureus
Samborska A, Karczewska M, Lichwala K, Szukalska S, Wróblewski K, Siwek L, Balajewicz B.   +6 more
europepmc   +1 more source

A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use [PDF]

, 2014
Mei‐Ling Blank, Lianne Parkin, Charlotte Paul, Peter Herbison   +3 more
openalex   +1 more source

Evaluation of the Long-Term Administration of Proton Pump Inhibitors (PPIs) in the Mineral Nutrient's Bioavailability. [PDF]

ACS Omega
de Brito AS, do Nascimento AN, Fonseca FLA, Fioroto AM, Petri G, do Nascimento RGV.   +5 more
europepmc   +1 more source